St Bartholomew's Hospital, Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London EC1A 7BE, UK; Institute of Cardiovascular Science, University College of London, London, UK.
St Bartholomew's Hospital, Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London EC1A 7BE, UK; Institute of Health Informatics, University College of London, London, UK.
Card Electrophysiol Clin. 2020 Sep;12(3):345-356. doi: 10.1016/j.ccep.2020.04.006. Epub 2020 Jun 27.
Brugada syndrome is an inherited cardiac condition characterized by a typical electrocardiogram signature of coved-type ST-segment elevation in the right precordial leads and ventricular arrhythmias leading to sudden cardiac death, in the absence of unequivocal structural heart disease. Brugada syndrome specifically affects the right ventricle, which predisposes to cardiac arrest. Besides medical management with quinidine, emerging data indicate that catheter ablation can help reduce the ventricular arrhythmia burden in these patients. This review explores the mechanisms of ventricular arrhythmia, current approaches and evidence for ablating the epicardial arrhythmogenic substrate in this condition.
Brugada 综合征是一种遗传性心脏病,其特征是右侧心前导联出现典型的穹窿型 ST 段抬高和室性心律失常,导致心脏性猝死,而无明确的结构性心脏病。Brugada 综合征特别影响右心室,使心脏骤停的风险增加。除了使用奎尼丁进行药物治疗外,新出现的数据表明,导管消融可以帮助减少这些患者的室性心律失常负担。本综述探讨了室性心律失常的机制,以及目前在这种情况下消融心外膜致心律失常基质的方法和证据。